OPALEYE MANAGEMENT INC.

Adviser information for OPALEYE MANAGEMENT INC. last updated from Form ADV on March 26th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Corporation
Fiscal Year End DECEMBER
Legal Location Massachusetts, United States

Employees

Total Number of Employees 4
Investment Advisory/Research 3
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 2 $432.5M
Non-Discretionary 0 $0
Total 2 $432.5M

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 1 $421.9M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers <5 $10.6M
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 50

Services

Advisory Services Portfolio management for pooled investment vehiclesPortfolio management for businesses or institutional clients
Compensation % of AUMPerformance-based fees

Identifiers

SEC RIA File Number 801-78700
SEC ERA File Number 801-78700
SEC CIK Numbers 1595855
SEC CRD Numbers 124513
Legal Entity Identifier None

Principal Office

ONE BOSTON PLACE
26TH FLOOR
BOSTON
MA
United States
Monday - Friday, 9:00 AM TO 5:00 PM, ET
Tel: 617-229-5085, Fax: None

Chief Compliance Officer

JAMES SILVERMAN
PRESIDENT
ONE BOSTON PLACE
26TH FLOOR
BOSTON
MA
United States
Tel: 617-229-5085
(Full email address available in API data)

Industry Affiliates

OPALEYE GP LLC Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
OPALEYE, L.P. Hedge Fund $421.8M $0.3M 63

Control Persons

Name Type Entity Title Since Ownership
SILVERMAN, JAMES, AARON Individual PRESIDENT/CHIEF COMPLIANCE OFFICER 02/1996 > 75%

No. Employees, Historic

10502020202120222023202420253 on 3/30/20203 on 3/31/20213 on 4/1/20223 on 10/7/20223 on 3/27/20234 on 3/26/2024

RAUM, Historic

900M450M0202020212022202320242025505126998 on 3/30/2020833440399 on 3/31/2021572206000 on 4/1/2022597658928 on 10/7/2022421979116 on 3/27/2023432480569 on 3/26/2024

No. Clients, Historic

703502020202120222023202420251 on 3/30/20202 on 3/31/202161 on 4/1/20222 on 10/7/20222 on 3/27/20232 on 3/26/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
4D MOLECULAR THERAPEUTICS INC COM 7M 346K
ABCELLERA BIOLOGICS INC COM 592K 200K
ACELYRIN INC COM 7M 2M
AEROVATE THERAPEUTICS INC COM 730K 440K
ALIGOS THERAPEUTICS INC COM 441K 1M
ALLAKOS INC COM 3M 3M
APPLIED THERAPEUTICS INC' COM 8M 2M
ARVINAS INC COM 15M 555K
BIODESIX INC COM 6M 4M
CARGO THERAPEUTICS INC COM 9M 556K
CATALYST PHARMACEUTICALS INC COM 10M 640K
CODEXIS INC COM 11M 3M
CYTOKINETICS INC COM NEW 11M 199K
DESIGN THERAPEUTICS INC COM 687K 205K
EDGEWISE THERAPEUTICS INC COM 10M 580K
ETON PHARMACEUTICALS INC COM 8M 2M
FULCRUM THERAPEUTICS INC COM 2M 285K
GOSSAMER BIO INC COM 4M 4M
GOSSAMER BIO INC NOTE 5.000% 6/0 4M
HARROW HEALTH INC COM 83M 4M
IBIO INC COM NEW 791K 375K
IMMUNOME INC COM 13M 1M
INTELLIA THERAPEUTICS INC COM 5M 218K
IOVANCE BIOTHERAPEUTICS INC COM 7M 897K
JASPER THERAPEUTICS INC COM NEW 9M 392K
KARYOPHARM THERAPEUTICS INC NOTE 3.000%10/1 4M
KARYOPHARM THERAPEUTICS INC COM 1M 1M
KEROS THERAPEUTICS INC COM 17M 368K
LEXICON PHARMACEUTICALS INC COM NEW 3M 2M
LIQUIDIA CORPORATION COM NEW 4M 325K
LYELL IMMUNOPHARMA INC COM 2M 2M
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES 6M 315K
NURIX THERAPEUTICS INC COM 9M 419K
NUVALENT INC COM 4M 59K
OCULAR THERAPEUTIX INC COM 36M 5M
PMV PHARMACEUTICALS INC COM 770K 475K
PROTAGONIST THERAPEUTICS INC COM 4M 105K
PROTARA THERAPEUTICS INC COM STK 5M 2M
REGULUS THERAPEUTICS INC COM 3M 1M
RELMADA THERAPEUTICS INC COM 2M 600K
RENEO PHARMACEUTICALS INC COM 249K 165K
RHYTHM PHARMACEUTICALS INC COM 21M 515K
SAVARA INC COM 3M 715K
SYROS PHARMACEUTICALS INC COM NEW 4M 865K
TG THERAPEUTICS INC COM 41M 2M
TREVI THERAPEUTICS INC COM 8M 3M
UROGEN PHARMA LTD COM 7M 412K
VAXCYTE INC COM 6M 85K
VENTYX BIOSCIENCES INC COM 3M 1M
VERASTEM INC COM NEW 3M 915K
XOMA CORP DEL COM NEW 6M 250K